CD8A and neoplasm: Since most tumor-reactive CD8+ T cells expressed T-bet, a transcription factor for Th1 or effector CD8+ T cells [13], we examined whether the treatment with CpG or Poly I:C would increase the frequency of T-bet+ CD8+ T cells.